newsfilter
← Latest News
Business Wire·

Humana Announces Agreement to Divest Minority Interest in Gentiva

  • Humana Inc. signed a definitive agreement to sell its minority interest in Gentiva, the nation's leading end-of-life services provider, for approximately $900 million.
  • The transaction is expected to close in the third quarter of 2026, pending regulatory approvals & other customary closing conditions.
  • Humana plans to use the sale proceeds for general corporate purposes & does not anticipate a material impact on 2026 earnings.
  • Humana's stake in Gentiva originated from its 2021 acquisition of Kindred at Home, which included an earlier commitment to divest non-core hospice & palliative businesses.
  • Gentiva was formed in 2022 after Humana sold a majority interest in its Kindred at Home hospice & personal care divisions to Clayton, Dubilier & Rice.
  • Guggenheim Securities served as financial advisor to Humana, while Fried, Frank, Harris, Shriver & Jacobson LLP & Manatt, Phelps & Phillips LLP acted as legal advisors.